Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Scpharmaceuticals Inc. (SCPH) since 2017 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Scpharmaceuticals Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1604950.
Total stock buying since 2017: $60,318,138.
Total stock sales since 2017: $5,998,431.
Total stock option exercises since 2017: $66,104.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 500,000 | $2,000,000 | 0 | $0 | 21,792 | $28,537 |
| 2022 | 762,380 | $4,002,495 | 1,096,622 | $4,935,858 | 42,250 | $0 |
| 2021 | 15,000 | $59,120 | 150,057 | $1,062,573 | 0 | $0 |
| 2020 | 2,237,310 | $19,230,333 | 0 | $0 | 42,250 | $0 |
| 2019 | 5,000 | $26,190 | 0 | $0 | 0 | $0 |
| 2017 | 2,500,000 | $35,000,000 | 0 | $0 | 22,631 | $37,567 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-08 | 500,000 | $2,000,000 | 0 | $0 | 21,792 | $28,537 |
| 2022-11 | 762,380 | $4,002,495 | 0 | $0 | 0 | $0 |
| 2022-10 | 0 | $0 | 600,000 | $2,488,905 | 42,250 | $0 |
| 2022-09 | 0 | $0 | 226,622 | $1,096,953 | 0 | $0 |
| 2022-04 | 0 | $0 | 270,000 | $1,350,000 | 0 | $0 |
| 2021-12 | 15,000 | $59,120 | 0 | $0 | 0 | $0 |
| 2021-03 | 0 | $0 | 150,057 | $1,062,573 | 0 | $0 |
| 2020-06 | 0 | $0 | 0 | $0 | 42,250 | $0 |
| 2020-05 | 1,965,317 | $16,999,991 | 0 | $0 | 0 | $0 |
| 2020-02 | 271,993 | $2,230,342 | 0 | $0 | 0 | $0 |
| 2019-12 | 5,000 | $26,190 | 0 | $0 | 0 | $0 |
| 2017-12 | 0 | $0 | 0 | $0 | 22,631 | $37,567 |
| 2017-11 | 2,500,000 | $35,000,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-08-26 | Schaeffer Leonard D | Option Ex | 11,347 | 2.52 | 28,537 |
| 2024-08-13 | Orbimed Genesis Gp Llc | Buy | 500,000 | 4.00 | 2,000,000 |
| 2024-08-06 | Nokes Rachael (CFO and Treasurer) | Option Ex | 10,445 | .00 | 0 |
| 2022-11-25 | Orbimed Genesis Gp Llc | Buy | 762,380 | 5.25 | 4,002,495 |
| 2022-10-10 | Schwab Andrew J. (10% Owner) | Sale | 562,466 | 4.09 | 2,300,485 |
| 2022-10-07 | Tucker John H (President and CEO) | Option Ex | 42,250 | .00 | 0 |
| 2022-10-06 | Schwab Andrew J. (10% Owner) | Sale | 37,534 | 5.02 | 188,420 |
| 2022-09-07 | Schwab Andrew J. (10% Owner) | Sale | 200,000 | 4.75 | 950,000 |
| 2022-09-06 | Schwab Andrew J. (10% Owner) | Sale | 26,622 | 5.52 | 146,953 |
| 2022-04-11 | Schwab Andrew J. (10% Owner) | Sale | 270,000 | 5.00 | 1,350,000 |
| 2021-12-03 | Khattar Jack A. (Director) | Buy | 5,000 | 3.91 | 19,570 |
| 2021-12-03 | Tucker John H (President and CEO) | Buy | 10,000 | 3.96 | 39,550 |
| 2021-03-15 | Shah Rajeev M. | Sale | 110,588 | 7.03 | 777,765 |
| 2021-03-12 | Shah Rajeev M. | Sale | 39,469 | 7.22 | 284,808 |
| 2020-06-30 | Tucker John H (President and CEO) | Option Ex | 42,250 | .00 | 0 |
| 2020-05-26 | Schwab Andrew J. (10% Owner) | Buy | 578,034 | 8.65 | 4,999,994 |
| 2020-05-21 | Orbimed Genesis Gp Llc | Buy | 1,387,283 | 8.65 | 11,999,997 |
| 2020-02-14 | Shah Rajeev M. | Buy | 271,993 | 8.20 | 2,230,342 |
| 2019-12-13 | Tucker John H (President and CEO) | Buy | 5,000 | 5.24 | 26,190 |
| 2017-12-19 | Schaeffer Leonard D (Director) | Option Ex | 22,631 | 1.66 | 37,567 |
| 2017-11-21 | Sun Pharmaceutical Industries, Inc. (10% Owner) | Buy | 357,143 | 14.00 | 5,000,002 |
| 2017-11-21 | Lundbeckfond Invest A/s (10% Owner) | Buy | 654,762 | 14.00 | 9,166,668 |
| 2017-11-21 | Rocklage Scott M (10% Owner) | Buy | 654,762 | 14.00 | 9,166,668 |
| 2017-11-21 | Isaly Samuel D (10% Owner) | Buy | 833,333 | 14.00 | 11,666,662 |
Insider trading activities including stock purchases, stock sales, and option exercises of SCPH listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Scpharmaceuticals Inc. (symbol SCPH, CIK number 1604950) see the Securities and Exchange Commission (SEC) website.